Literature DB >> 22547090

Virus-mediated inhibition of natural cytotoxicity receptor recognition.

Einat Seidel1, Ariella Glasner, Ofer Mandelboim.   

Abstract

Natural killer (NK) cells are a part of the innate immune system that functions mainly to kill transformed and infected cells. Their activity is controlled by signals derived from a panel of activating and inhibitory receptors. The natural cytotoxicity receptors (NCRs): NKp30, NKp44, and NKp46 (NCR1 in mice) are prominent among the activating NK cell receptors and they are, notably, the only NK-activating receptors that are able to recognize pathogen-derived ligands. In addition, the NCRs also recognize cellular ligands, the identity of which remains largely unknown. In this review, we summarize the current knowledge regarding viruses that are recognized by the NCRs, focusing on the diverse immune-evasion mechanisms employed by viruses to escape this detection. We also discuss the unique role the NCRs have in regulating NK cell activity with particular emphasis on the in vivo function of NKp46/NCR1.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22547090     DOI: 10.1007/s00018-012-1001-x

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.207


  86 in total

1.  NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells.

Authors:  S Sivori; D Pende; C Bottino; E Marcenaro; A Pessino; R Biassoni; L Moretta; A Moretta
Journal:  Eur J Immunol       Date:  1999-05       Impact factor: 5.532

2.  NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies.

Authors:  Giuliana Magri; Aura Muntasell; Neus Romo; Andrea Sáez-Borderías; Daniela Pende; Daniel E Geraghty; Hartmut Hengel; Ana Angulo; Alessandro Moretta; Miguel López-Botet
Journal:  Blood       Date:  2010-10-28       Impact factor: 22.113

Review 3.  An integrated view of the regulation of NKG2D ligands.

Authors:  Noam Stern-Ginossar; Ofer Mandelboim
Journal:  Immunology       Date:  2009-09       Impact factor: 7.397

Review 4.  Up on the tightrope: natural killer cell activation and inhibition.

Authors:  Lewis L Lanier
Journal:  Nat Immunol       Date:  2008-05       Impact factor: 25.606

5.  Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells.

Authors:  O Mandelboim; N Lieberman; M Lev; L Paul; T I Arnon; Y Bushkin; D M Davis; J L Strominger; J W Yewdell; A Porgador
Journal:  Nature       Date:  2001-02-22       Impact factor: 49.962

6.  Ligands for natural killer cell-activating receptors are expressed upon the maturation of normal myelomonocytic cells but at low levels in acute myeloid leukemias.

Authors:  Pegah Nowbakht; Mihai-Constantin S Ionescu; Andreas Rohner; Christian P Kalberer; Emmanuel Rossy; Lucia Mori; David Cosman; Gennaro De Libero; Aleksandra Wodnar-Filipowicz
Journal:  Blood       Date:  2005-01-18       Impact factor: 22.113

7.  HIV escape from natural killer cytotoxicity: nef inhibits NKp44L expression on CD4+ T cells.

Authors:  Hugues Fausther-Bovendo; Nathalie Sol-Foulon; Daniel Candotti; Henri Agut; Olivier Schwartz; Patrice Debré; Vincent Vieillard
Journal:  AIDS       Date:  2009-06-01       Impact factor: 4.177

8.  HIV modulates the expression of ligands important in triggering natural killer cell cytotoxic responses on infected primary T-cell blasts.

Authors:  Jeffrey Ward; Matthew Bonaparte; Jennifer Sacks; Jacqueline Guterman; Manuela Fogli; Domenico Mavilio; Edward Barker
Journal:  Blood       Date:  2007-05-18       Impact factor: 22.113

9.  Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells.

Authors:  Elke Pogge von Strandmann; Venkateswara Rao Simhadri; Bastian von Tresckow; Stephanie Sasse; Katrin S Reiners; Hinrich P Hansen; Achim Rothe; Boris Böll; Vijaya Lakshmi Simhadri; Peter Borchmann; Peter J McKinnon; Michael Hallek; Andreas Engert
Journal:  Immunity       Date:  2007-12-06       Impact factor: 31.745

10.  Structure of the human activating natural cytotoxicity receptor NKp30 bound to its tumor cell ligand B7-H6.

Authors:  Yili Li; Qian Wang; Roy A Mariuzza
Journal:  J Exp Med       Date:  2011-03-21       Impact factor: 14.307

View more
  27 in total

1.  Homo-oligomerization of the activating natural killer cell receptor NKp30 ectodomain increases its binding affinity for cellular ligands.

Authors:  Julia Herrmann; Hannah Berberich; Jessica Hartmann; Steffen Beyer; Karen Davies; Joachim Koch
Journal:  J Biol Chem       Date:  2013-11-25       Impact factor: 5.157

2.  Receptors for non-MHC ligands contribute to uterine natural killer cell activation during pregnancy in mice.

Authors:  A M Felker; Z Chen; W G Foster; B A Croy
Journal:  Placenta       Date:  2013-06-24       Impact factor: 3.481

Review 3.  Fusobacterium nucleatum, inflammation, and immunity: the fire within human gut.

Authors:  Arif Bashir; Abid Yousuf Miskeen; Younis Mohammad Hazari; Syed Asrafuzzaman; Khalid Majid Fazili
Journal:  Tumour Biol       Date:  2015-12-30

4.  Human Herpesvirus 6B Downregulates Expression of Activating Ligands during Lytic Infection To Escape Elimination by Natural Killer Cells.

Authors:  Dominik Schmiedel; Julie Tai; Francesca Levi-Schaffer; Sarah Dovrat; Ofer Mandelboim
Journal:  J Virol       Date:  2016-10-14       Impact factor: 5.103

5.  NKp30 isoforms in patients with chronic hepatitis C virus infection.

Authors:  Stefania Mantovani; Dalila Mele; Barbara Oliviero; Giorgio Barbarini; Stefania Varchetta; Mario U Mondelli
Journal:  Immunology       Date:  2015-07-08       Impact factor: 7.397

6.  Zika Virus Escapes NK Cell Detection by Upregulating Major Histocompatibility Complex Class I Molecules.

Authors:  Ariella Glasner; Esther Oiknine-Djian; Yiska Weisblum; Mohammad Diab; Amos Panet; Dana G Wolf; Ofer Mandelboim
Journal:  J Virol       Date:  2017-10-27       Impact factor: 5.103

7.  Natural killer cell-mediated host defense against uropathogenic E. coli is counteracted by bacterial hemolysinA-dependent killing of NK cells.

Authors:  Chamutal Gur; Shunit Coppenhagen-Glazer; Shilo Rosenberg; Rachel Yamin; Jonatan Enk; Ariella Glasner; Yotam Bar-On; Omer Fleissig; Ronit Naor; Jawad Abed; Dror Mevorach; Zvi Granot; Gilad Bachrach; Ofer Mandelboim
Journal:  Cell Host Microbe       Date:  2013-12-11       Impact factor: 21.023

8.  Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack.

Authors:  Chamutal Gur; Yara Ibrahim; Batya Isaacson; Rachel Yamin; Jawad Abed; Moriya Gamliel; Jonatan Enk; Yotam Bar-On; Noah Stanietsky-Kaynan; Shunit Coppenhagen-Glazer; Noam Shussman; Gideon Almogy; Angelica Cuapio; Erhard Hofer; Dror Mevorach; Adi Tabib; Rona Ortenberg; Gal Markel; Karmela Miklić; Stipan Jonjic; Caitlin A Brennan; Wendy S Garrett; Gilad Bachrach; Ofer Mandelboim
Journal:  Immunity       Date:  2015-02-10       Impact factor: 31.745

9.  Influenza virus uses its neuraminidase protein to evade the recognition of two activating NK cell receptors.

Authors:  Yotam Bar-On; Einat Seidel; Pinchas Tsukerman; Michal Mandelboim; Ofer Mandelboim
Journal:  J Infect Dis       Date:  2014-02-14       Impact factor: 5.226

10.  HSV-2 specifically down regulates HLA-C expression to render HSV-2-infected DCs susceptible to NK cell killing.

Authors:  Moran Elboim; Inna Grodzovski; Esther Djian; Dana G Wolf; Ofer Mandelboim
Journal:  PLoS Pathog       Date:  2013-03-28       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.